Agios Pharm Stock Widgets and Gadgets
| AGIO Stock | USD 58.66 0.44 0.74% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- AGIO Agios Pharm
- Latest Is Agios Pharmaceuticals Stock Outpacing Its Medical Peers This Year
- AGIO 58.66 -0.44
- Low 57.98
- High 59.62
- Alpha 0.11
- Beta 2.2
- Return On Equity 0.54
- Return On Asset -0.18
- Profit Margin 20.51 %
- Operating Margin (11.47) %
- Current Valuation 2.4 B
- Shares Outstanding 57.03 M
- Shares Owned By Insiders 1.50 %
- Shares Owned By Institutions 98.50 %
- Number Of Shares Shorted 4.55 M
- Price To Earning 1.26 X
- Price To Book 2.06 X
- Price To Sales 101.77 X
- Revenue 26.82 M
- Gross Profit 12.54 M
- EBITDA (384.86 M)
- Net Income (352.09 M)
- Cash And Equivalents 819.31 M
- Cash Per Share 14.95 X
- Total Debt 72 M
- Debt To Equity 0.08 %
- Current Ratio 17.98 X
- Book Value Per Share 28.53 X
- Cash Flow From Operations (296.06 M)
- Short Ratio 6.65 X
- Earnings Per Share 11.66 X
- Target Price 53.88
- Number Of Employees 383
- Beta 0.75
- Market Capitalization 3.35 B
- Total Asset 937.12 M
- Retained Earnings (822.65 M)
- Working Capital 765.88 M
- Current Asset 337.33 M
- Current Liabilities 52.89 M
- Net Asset 937.12 M
- Accumulation Distribution 0.0275
- Daily Balance Of Power (0.27)
- Rate Of Daily Change 0.99
- Day Median Price 58.8
- Day Typical Price 58.75
- Market Facilitation Index 1.64
- Price Action Indicator (0.36)
- Period Momentum Indicator (0.44)
Market Snapshot Widget Example
DAX Index Germany | 19,426 0.85 | |
Taiwan Weighted Taiwan | 22,299 0.16 | |
PSI 20 Stock Portugal | 6,431 0.20 | |
CROBEX Croatia | 3,159 0.26 | |
Budapest SE Hungary | 78,374 0.83 | |
IDX 30 Jakarta Indonesia | 447.75 0.92 | |
ISEQ 20 Price Ireland | 1,594 0.58 | |
NYSE Comp USA | 20,210 0.05 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,106 1.00 | |
IPC MEXICO Mexico | 49,861 0.05 | |
KL Technology Malaysia | 58.73 1.56 | |
IBEX 35 Index Spain | 11,611 0.27 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,529 0.63 | |
SPASX Dividend Opportunities Australia | 1,696 0.33 | |
HNX 30 Vietnam | 474.27 0.32 | |
Bucharest BET-NG Romania | 1,209 0.20 | |
AMS Small Cap Netherlands | 1,215 3.41 | |
Oslo Exchange Mutual Norway | 1,413 0.06 | |
BEL Small Belgium | 8,045 0.09 | |
Basic Materials Brazil | 5,771 0.17 | |
Swiss Leader Price Switzerland | 1,929 0.49 | |
Fondo Mutuo ETF Chile | 1,362 0.28 | |
Athens General Comp Greece | 1,404 0.01 | |
Stock Exchange Of Thailand | 1,428 0.17 | |
PX Prague Stock Czech Repub | 1,689 0.35 | |
THE PHILIPPINE STOCK Philippines | 6,639 0.96 | |
WIG 30 Poland | 2,801 0.2 | |
BIST Electricity Turkey | 489.17 0.36 |
Investing Ideas
In addition to having Agios Pharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Agios Pharm
Compare Agios Pharm To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 11.66 | Revenue Per Share 0.582 | Quarterly Revenue Growth 0.212 | Return On Assets (0.18) | Return On Equity 0.5366 |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.